2004 2003 2002 2000-2001

Scripps NeuroAIDS Preclinical Studies (SNAPS) Center
Supported by the National Institute for Mental Health
P30 MH62261
Publications 2002

  1. Al-Khatib, K., I.L. Campbell, and D.J. Carr, Resistance to ocular herpes simplex virus type 1 infection in IL-12 transgenic mice. J Neuroimmunol, 2002. 132:41-8.
  2. Boztug, K., M.J. Carson, N. Pham-Mitchell, V.C. Asensio, J. DeMartino, and I.L. Campbell, Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. J Immunol, 2002. 169:1505-15.
  3. Burudi, E.M., M.C. Marcondes, D.D. Watry, M. Zandonatti, M.A. Taffe, and H.S. Fox, Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. J Virol, 2002. 76:12233-41.
  4. Carr, D.J., J. Ash, K. Al-Khatib, and I.L. Campbell, Unforeseen consequences of IL-12 expression in the eye of GFAP-IL12 transgenic mice following herpes simplex virus type 1 infection. DNA Cell Biol, 2002. 21:467-73.
  5. Chismar, J.D., T. Mondala, H.S. Fox, E. Roberts, D. Langford, E. Masliah, D.R. Salomon, and S.R. Head, Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations. Biotechniques, 2002. 33:516-8, 520, 522 passim.
  6. Danielson, P.E., L.N. Sautkulis, P.E. Foye, P.B. Hedlund, and M.J. Carson, A novel mRNA expressed along brain ventricles. Brain Res Gene Expr Patterns, 2002. 1:83-8.
  7. Flodstrom, M., A. Maday, D. Balakrishna, M.M. Cleary, A. Yoshimura, and N. Sarvetnick, Target cell defense prevents the development of diabetes after viral infection. Nat Immunol, 2002. 3:373-82.
  8. Freude, S., J. Hausmann, M. Hofer, N. Pham-Mitchell, I.L. Campbell, P. Staeheli, and A. Pagenstecher, Borna disease virus accelerates inflammation and disease associated with transgenic expression of interleukin-12 in the central nervous system. J Virol, 2002. 76:12223-32.
  9. Giralt, M., M. Penkowa, J. Hernandez, A. Molinero, J. Carrasco, N. Lago, J. Camats, I.L. Campbell, and J. Hidalgo, Metallothionein-1+2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6. Neurobiol Dis, 2002. 9:319-38.
  10. Huang, J., P.F. Lo, T. Zal, N.R. Gascoigne, B.A. Smith, S.D. Levin, and H.M. Grey, CD28 plays a critical role in the segregation of PKC theta within the immunologic synapse. Proc Natl Acad Sci U S A, 2002. 99:9369-73.
  11. Huitron-Resendiz, S., M. Sanchez-Alavez, R. Gallegos, G. Berg, E. Crawford, J.L. Giacchino, D. Games, S.J. Henriksen, and J.R. Criado, Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res, 2002. 928:126-37.
  12. Kim, S.H., M.M. Cleary, H.S. Fox, D. Chantry, and N. Sarvetnick, CCR4-bearing T cells participate in autoimmune diabetes. J Clin Invest, 2002. 110:1675-86.
  13. Maier, J., C. Kincaid, A. Pagenstecher, and I.L. Campbell, Regulation of signal transducer and activator of transcription and suppressor of cytokine-signaling gene expression in the brain of mice with astrocyte-targeted production of interleukin-12 or experimental autoimmune encephalomyelitis. Am J Pathol, 2002. 160:271-88.
  14. Martin, G., V. Fabre, G.R. Siggins, and L. de Lecea, Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul Pept, 2002. 104:111-7.
  15. Milner, R. and I.L. Campbell, Developmental regulation of beta1 integrins during angiogenesis in the central nervous system. Mol Cell Neurosci, 2002. 20:616-26.
  16. Milner, R. and I.L. Campbell, Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin. J Neurosci, 2002. 22:1562-72.
  17. Moore, J.E., T.C. McMullen, I.L. Campbell, R. Rohan, Y. Kaji, N.A. Afshari, T. Usui, D.B. Archer, and A.P. Adamis, The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy. Invest Ophthalmol Vis Sci, 2002. 43:2905-15.
  18. Nelson, T.E., C.L. Ur, and D.L. Gruol, Chronic interleukin-6 exposure alters electrophysiological properties and calcium signaling in developing cerebellar purkinje neurons in culture. J Neurophysiol, 2002. 88:475-86.
  19. Offer, J., C.N. Boddy, and P.E. Dawson, Extending synthetic access to proteins with a removable acyl transfer auxiliary. J Am Chem Soc, 2002. 124:4642-6.
  20. Polich, J. and S. Basho, P3a and P3b auditory ERPs in HIV patients receiving anti-viral medication. Clin Electroencephalogr, 2002. 33:97-101.
  21. Puffer, B.A., S. Pohlmann, A.L. Edinger, D. Carlin, M.D. Sanchez, J. Reitter, D.D. Watry, H.S. Fox, R.C. Desrosiers, and R.W. Doms, CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J Virol, 2002. 76:2595-605.
  22. Reiman, R., C. Gerard, I.L. Campbell, and S.R. Barnum, Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis. Eur J Immunol, 2002. 32:1157-63.
  23. Schmid, C.D., L.N. Sautkulis, P.E. Danielson, J. Cooper, K.W. Hasel, B.S. Hilbush, J.G. Sutcliffe, and M.J. Carson, Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem, 2002. 83:1309-20.
  24. Strack, A., D. Schluter, V.C. Asensio, I.L. Campbell, and M. Deckert, Regulation of the kinetics of intracerebral chemokine gene expression in murine Toxoplasma encephalitis: impact of host genetic factors. Glia, 2002. 40:372-7.
  25. Valdez, G.R., A.J. Roberts, K. Chan, H. Davis, M. Brennan, E.P. Zorrilla, and G.F. Koob, Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res, 2002. 26:1494-501.
  26. Vallieres, L., I.L. Campbell, F.H. Gage, and P.E. Sawchenko, Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci, 2002. 22:486-92.
  27. Venturini, S., D.E. Mosier, D.R. Burton, and P. Poignard, Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization. J Virol, 2002. 76:6987-99.
  28. Wang, J., R.D. Schreiber, and I.L. Campbell, STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system. Proc Natl Acad Sci U S A, 2002. 99:16209-14.
  29. Yegneswaran, S., J.A. Fernandez, J.H. Griffin, and P.E. Dawson, Factor Va increases the affinity of factor Xa for prothrombin: a binding study using a novel photoactivable thiol-specific fluorescent probe. Chem Biol, 2002. 9:485-94.
  30. Zal, T., M.A. Zal, and N.R. Gascoigne, Inhibition of T cell receptor-coreceptor interactions by antagonist ligands visualized by live FRET imaging of the T-hybridoma immunological synapse. Immunity, 2002. 16:521-34.